Title
Category
Credits
Event date
Cost
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the neurology and neurobiology components of substance use disorder along with explaining the similarities between substance use disorder and chronic disease.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding overdose risk factors, signs, and response around opioids and related drugs.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session explaining co-occurring conditions that often coincide with substance use disorder.
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session explaining the assessment, diagnosis, and risk factors of substance use disorder.
  • ALAHOPE Substance Use
  • 0.60 ABN
  • 0.50 ABSWE
  • 0.50 ACPE Pharmacy
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
  • 0.50 BDEA
$0.00
An interactive, online training session regarding treating opioid use disorder with FDA approved medications along with common challenges found during such treatment.
  • Alabama Community Engagement Alliance against COVID-19 Disparities (Alabama CEAL)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
$0.00
A review of the newest evidence for using COVID-19 therapeutics and a review of pipeline antivirals.
  • Alabama Community Engagement Alliance against COVID-19 Disparities (Alabama CEAL)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
$0.00
  • Social Determinants of Health
  • 1.00 ACPE Pharmacy
$0.00
Social determinants of health (SDoH) are linked to diabetes and prediabetes prevalence, poorly controlled diabetes, and cardiometabolic disease disparities leading to national calls to address upstream SDoH to improve health equity. In order to act upon SDoH – either through tailored care delivery or social referral outside of the health system – clinicians must first be able to screen for adverse SDoH, or social risks.

Pages